168 related articles for article (PubMed ID: 31200854)
1. Structurally-defined deubiquitinase inhibitors provide opportunities to investigate disease mechanisms.
Wertz IE; Murray JM
Drug Discov Today Technol; 2019 Apr; 31():109-123. PubMed ID: 31200854
[TBL] [Abstract][Full Text] [Related]
2. Small-Molecule Inhibitors Targeting Proteasome-Associated Deubiquitinases.
Moon S; Muniyappan S; Lee SB; Lee BH
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207520
[TBL] [Abstract][Full Text] [Related]
3. Small molecule inhibitors reveal allosteric regulation of USP14 via steric blockade.
Wang Y; Jiang Y; Ding S; Li J; Song N; Ren Y; Hong D; Wu C; Li B; Wang F; He W; Wang J; Mei Z
Cell Res; 2018 Dec; 28(12):1186-1194. PubMed ID: 30254335
[TBL] [Abstract][Full Text] [Related]
4. Neurotoxic mechanisms by which the USP14 inhibitor IU1 depletes ubiquitinated proteins and Tau in rat cerebral cortical neurons: Relevance to Alzheimer's disease.
Kiprowska MJ; Stepanova A; Todaro DR; Galkin A; Haas A; Wilson SM; Figueiredo-Pereira ME
Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1157-1170. PubMed ID: 28372990
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitinated proteins promote the association of proteasomes with the deubiquitinating enzyme Usp14 and the ubiquitin ligase Ube3c.
Kuo CL; Goldberg AL
Proc Natl Acad Sci U S A; 2017 Apr; 114(17):E3404-E3413. PubMed ID: 28396413
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-specific protease 14 regulates c-Jun N-terminal kinase signaling at the neuromuscular junction.
Vaden JH; Bhattacharyya BJ; Chen PC; Watson JA; Marshall AG; Phillips SE; Wilson JA; King GD; Miller RJ; Wilson SM
Mol Neurodegener; 2015 Jan; 10():3. PubMed ID: 25575639
[TBL] [Abstract][Full Text] [Related]
7. Spongiacidin C, a pyrrole alkaloid from the marine sponge Stylissa massa, functions as a USP7 inhibitor.
Yamaguchi M; Miyazaki M; Kodrasov MP; Rotinsulu H; Losung F; Mangindaan RE; de Voogd NJ; Yokosawa H; Nicholson B; Tsukamoto S
Bioorg Med Chem Lett; 2013 Jul; 23(13):3884-6. PubMed ID: 23684893
[TBL] [Abstract][Full Text] [Related]
8. Deubiquitinases Modulate Platelet Proteome Ubiquitination, Aggregation, and Thrombosis.
Gupta N; Li W; McIntyre TM
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2657-66. PubMed ID: 26471267
[TBL] [Abstract][Full Text] [Related]
9. Emerging role of ubiquitin-specific protease 14 in oncogenesis and development of tumor: Therapeutic implication.
Liu B; Chen J; Zhang S
Life Sci; 2019 Dec; 239():116875. PubMed ID: 31676235
[TBL] [Abstract][Full Text] [Related]
10. Cellular Assays for Dynamic Quantification of Deubiquitinase Activity and Inhibition.
Moghadasi SA; Moraes SN; Harris RS
J Mol Biol; 2023 Dec; 435(23):168316. PubMed ID: 37858708
[TBL] [Abstract][Full Text] [Related]
11. USP14 Inhibition Regulates Tumorigenesis by Inducing Autophagy in Lung Cancer In Vitro.
Han KH; Kwak M; Lee TH; Park MS; Jeong IH; Kim MJ; Jin JO; Lee PC
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653087
[TBL] [Abstract][Full Text] [Related]
12. Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenström macroglobulinaemia tumour cells.
Chitta K; Paulus A; Akhtar S; Blake MK; Caulfield TR; Novak AJ; Ansell SM; Advani P; Ailawadhi S; Sher T; Linder S; Chanan-Khan A
Br J Haematol; 2015 May; 169(3):377-90. PubMed ID: 25691154
[TBL] [Abstract][Full Text] [Related]
13. An inhibitor of the proteasomal deubiquitinating enzyme USP14 induces tau elimination in cultured neurons.
Boselli M; Lee BH; Robert J; Prado MA; Min SW; Cheng C; Silva MC; Seong C; Elsasser S; Hatle KM; Gahman TC; Gygi SP; Haggarty SJ; Gan L; King RW; Finley D
J Biol Chem; 2017 Nov; 292(47):19209-19225. PubMed ID: 28972160
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin-specific protease 14 is a new therapeutic target for the treatment of diseases.
Wang D; Ma H; Zhao Y; Zhao J
J Cell Physiol; 2021 May; 236(5):3396-3405. PubMed ID: 33135160
[TBL] [Abstract][Full Text] [Related]
15. A small-molecule inhibitor of deubiquitinating enzyme USP14 inhibits Dengue virus replication.
Nag DK; Finley D
Virus Res; 2012 Apr; 165(1):103-6. PubMed ID: 22306365
[TBL] [Abstract][Full Text] [Related]
16. (1)H, (13)C and (15)N backbone resonance assignment for the 40.5 kDa catalytic domain of Ubiquitin Specific Protease 7 (USP7).
Di Lello P; Rougé L; Pan B; Maurer T
Biomol NMR Assign; 2016 Oct; 10(2):345-9. PubMed ID: 27386854
[TBL] [Abstract][Full Text] [Related]
17. USP7 deubiquitinase controls HIV-1 production by stabilizing Tat protein.
Ali A; Raja R; Farooqui SR; Ahmad S; Banerjea AC
Biochem J; 2017 May; 474(10):1653-1668. PubMed ID: 28280111
[TBL] [Abstract][Full Text] [Related]
18. Molecular Understanding of USP7 Substrate Recognition and C-Terminal Activation.
Rougé L; Bainbridge TW; Kwok M; Tong R; Di Lello P; Wertz IE; Maurer T; Ernst JA; Murray J
Structure; 2016 Aug; 24(8):1335-1345. PubMed ID: 27452404
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of proteasome activity by a small-molecule inhibitor of USP14.
Lee BH; Lee MJ; Park S; Oh DC; Elsasser S; Chen PC; Gartner C; Dimova N; Hanna J; Gygi SP; Wilson SM; King RW; Finley D
Nature; 2010 Sep; 467(7312):179-84. PubMed ID: 20829789
[TBL] [Abstract][Full Text] [Related]
20. Generation and Validation of Intracellular Ubiquitin Variant Inhibitors for USP7 and USP10.
Zhang W; Sartori MA; Makhnevych T; Federowicz KE; Dong X; Liu L; Nim S; Dong A; Yang J; Li Y; Haddad D; Ernst A; Heerding D; Tong Y; Moffat J; Sidhu SS
J Mol Biol; 2017 Nov; 429(22):3546-3560. PubMed ID: 28587923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]